YUMSHOQ TO‘QIMALAR SARKOMALARINING IMMUN MIKROMUHITI: TERAPİYA SAMARALILIGINI BASHQARISHDA T-LIMFOTSITLAR VA MAKROFAGLARNING O‘RNI
##article.subject##:
sarkoma, T-limfotsit, mikromuhit, kimyoterapiya##article.abstract##
Ushbu maqola T-limfotsitlar (CD4+, CD8+) va makrofaglar (CD68+) kabi yumshoq to‘qima sarkomalari immun mikromuhiti tarkibiy qismlarining ahamiyatini va ularning o‘sma strukturalari ichida joylashishini o‘rganishga bag‘ishlangan. Tahlil ushbu immun hujayralarining faolligi va joylashuvi bilan terapevtik patomorfoz darajasi o‘rtasidagi bog‘liqlikni aniqlashga imkon beradi, bu esa muhim prognostik belgi bo‘lib xizmat qiladi. Natijalar shuni ko‘rsatadiki, o‘sma ichidagi faol immun infiltratlar yanada aniq morfologik regressiya va yuqori darajadagi patomorfozga hissa qo‘shadi, bu esa ijobiy terapevtik natijalar bilan bog‘liq. Shu bilan birga, immun hujayralarining joylashuvi va holatini o‘rganish prognostik baholash va individual immunoterapiya strategiyalarini ishlab chiqish uchun yangi imkoniyatlar yaratadi. Olingan ma’lumotlar shuni ko‘rsatadiki, immun mikromuhit parametrlari yumshoq to‘qimalar sarkomasini davolashni optimallashtirish va ularning samaradorligini oshirishda muhim vosita bo‘lishi mumkin.
Библиографические ссылки
Huang H, Fan Y, Zhang S, Bai X, Wang X, Shan F. Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review. Front Immunol. 2025 May 21;16:1507870. doi: 10.3389/fimmu.2025.1507870. PMID: 40469285; PMCID: PMC12133756
van der Graaf WTA, Orbach D, Judson IR, Ferrari A. Soft tissue sarcomas in adolescents and young adults: A comparison with their paediatric and adult counterparts. Lancet Oncol. (2017) 18:e166–e75. doi: 10.1016/s1470-2045(17)30099-2
Lee AQ, Hao C, Pan M, Ganjoo KN, Bui N. Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. J Clin Oncol. (2024) 42:11569. doi: 10.1200/JCO.2024.42.16_suppl.11569
Wood GE, Meyer C, Petitprez F, D’Angelo SP. Immunotherapy in sarcoma: current data and promising strategies. Am Soc Clin Oncol Educ Book. (2024) 44:e432234. doi: 10.1200/edbk_432234
Recine F, Vanni S, Bongiovanni A, Fausti V, Mercatali L, Miserocchi G, et al. Clinical and translational implications of immunotherapy in sarcomas. Front Immunol. (2024) 15:1378398. doi: 10.3389/fimmu.2024.1378398
Раза, М., Ризаев, Ж., & Джурабекова, А. (2025). Организационно-адаптационные стратегии улучшения социально-психологической интеграции зарубежных учащихся медицинских вузов. Наука и инновация, 3(15), 37–39.
Rizaev JA, Maeda H., Khramova NV Plastic surgery for the defects in the maxillofacial region after surgical resection of benign tumors //Annals of Cancer Research and Therapy. – 2019. – T. 27. – no. 1. – S. 22-23.
Rizaev Jasur , Norbutayev Alisher, Murtazayev Alisher . Modern methods for detecting oral cavity defects in hemoblastosis , detecting the degree of damage and prediction of the clinical current. Journal of Biomedicine and Practice. 2021, vol. 6, issue 5, pp. 45-51
Shavkatovna, S. S., Makhammatkulovich, R. N., & Ugli, M. S. T. (2024). Aspects of sarcopenia syndrome in oncological practice: Diagnosis and treatment. The American Journal of Medical Sciences and Pharmaceutical Research, 6(2).
Shakhanova, S. S., & Rakhimov, N. M. (2025). The role of troponin and IL-6 in immunological assessment of sarcopenia in oncological patients. Central Asian Journal of Medical and Natural Science, 6(3), 1229–1233.
Rakhimov, N. M., & Shakhanova, S. Sh. (2025). Omega-3 supplementation in combination therapy for anorexia syndrome in metastatic breast cancer. American Journal of Medicine and Medical Sciences.
